Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II study of olaparib in BRCA-mutated previously treated advanced ovarian cancer
2014-002014-22Phase 2Terminated
- Sponsor
- Országos Onkológiai Intézet
- Start
- May 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of olaparib in ovarian cancer, sponsored by Országos Onkológiai Intézet. Primary endpoints: Progression-free survival and Progression of cancer. Started May 2014; status: terminated.
02
Drugs
olaparib
03
Conditions
ovarian cancer
Beyond the preview
Go deeper on 2014-002014-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-002014-22.